Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...
BILLERICA, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results